Stockscreener 앱 받기
73.56
0.91%
0.70
전일 마감가:
$72.86
열려 있는:
$72.95
하루 거래량:
2.93M
Relative Volume:
0.48
시가총액:
$28.73B
수익:
$4.30B
순이익/손실:
$571.50M
주가수익비율:
51.49
EPS:
1.4285
순현금흐름:
$570.80M
1주 성능:
+5.73%
1개월 성능:
+8.81%
6개월 성능:
-17.38%
1년 성능:
-17.15%
1일 변동 폭
$72.65
$73.70
1주일 범위
$68.54
$75.97
52주 변동 폭
$54.11
$93.25
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
DXCM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
73.66 | 28.42B | 4.30B | 571.50M | 570.80M | 1.4285 |
|
ABT
Abbott Laboratories
|
108.33 | 186.79B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
94.19 | 137.19B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
358.35 | 135.78B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.29 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.15 | 48.55B | 5.88B | 1.34B | 799.60M | 2.3489 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-12 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2025-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 개시 | Evercore ISI | In-line |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
Mitsubishi UFJ Trust & Banking Corp Sells 102,717 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Purchased by Sector Gamma AS - MarketBeat
Rakuten Investment Management Inc. Buys New Position in DexCom, Inc. $DXCM - MarketBeat
How Investors Are Reacting To DexCom (DXCM) Revenue Guidance After G7 Recall and CGM Expansion Plans - simplywall.st
Jennison Associates LLC Has $678.98 Million Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Teacher Retirement System of Texas Acquires 92,643 Shares of DexCom, Inc. $DXCM - MarketBeat
Baillie Gifford & Co. Sells 823,027 Shares of DexCom, Inc. $DXCM - MarketBeat
New DexCom CEO Remains Focused on Addressing Recent Quality Issues - Morningstar
DexCom Inc (DXCM) Trading 4.47% Higher on Jan 22 - GuruFocus
Campbell & CO Investment Adviser LLC Has $629,000 Holdings in DexCom, Inc. $DXCM - MarketBeat
Allstate Corp Invests $964,000 in DexCom, Inc. $DXCM - MarketBeat
Dexcom Reports 22% Revenue Growth to $1.2 Billion in 2024 Amidst Challenges - Intellectia AI
Analysts Offer Insights on Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Dexcom (DXCM) - The Globe and Mail
FDA Flags Serious Software Issue in Dexcom Glucose Monitoring App - Drugwatch.com
Analysts Are Bullish on Top Healthcare Stocks: Dexcom (DXCM), AbbVie (ABBV) - The Globe and Mail
DexCom Inc. (NASDAQ:DXCM) Combines Strong Fundamentals with Bullish Chart Pattern - Chartmill
Fisher Funds Management LTD Sells 91,159 Shares of DexCom, Inc. $DXCM - MarketBeat
Market Pulse: Can DexCom Inc be the next market leader2025 Technical Patterns & Detailed Earnings Play Strategies - baoquankhu1.vn
Assessing DexCom (DXCM) Valuation After Recent Share Price Momentum And Conflicting Fair Value Signals - Yahoo Finance
Dexcom (DXCM) releases preliminary, unaudited results for Q4 2025 - MSN
Is Dexcom the Next Sleeper Stock? The Real Talk on This Glucose Tech Giant - AD HOC NEWS
DexCom, Inc. $DXCM Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Here's why you should hold DexCom stock in your portfolio for now - MSN
Pinnacle Financial Partners Inc Sells 33,980 Shares of DexCom, Inc. $DXCM - MarketBeat
Stephens Investment Management Group LLC Sells 16,732 Shares of DexCom, Inc. $DXCM - MarketBeat
Nordea Investment Management AB Boosts Stake in DexCom, Inc. $DXCM - MarketBeat
Is DexCom Stock Underperforming the S&P 500? - MSN
DexCom Stock Declines Following Strong Preliminary Q4 Results - Yahoo Finance
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now - Finviz
MGO One Seven LLC Buys 14,699 Shares of DexCom, Inc. $DXCM - MarketBeat
How Do Investors Really Feel About DexCom Inc? - Benzinga
Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights - marketscreener.com
Dexcom CEO Talks G8 CGM Sensor - Medical Device and Diagnostic industry
Palmetto Grain Brokerage - Palmetto Grain Brokerage
DexCom's Q4 2025 Earnings: What to Expect - Yahoo Finance
Dexcom’s new CEO talks affordability, over-the-counter glucose sensors - Healthcare Brew
New Dexcom CEO Jake Leach talks 2026 roadmap, next-gen tech - MassDevice
DexCom (DXCM) Releases Preliminary, Unaudited Results for Q4 2025 - Insider Monkey
Dexcom’s Jake Leach on the future of continuous glucose monitoring - Modern Healthcare
Is DexCom (DXCM) Pricing Justified After Recent Multi Year Share Price Weakness - Yahoo Finance
RWC Asset Management LLP Cuts Holdings in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Bought by PKO Investment Management Joint Stock Co - MarketBeat
JPM26: Dexcom’s new CEO eyes international CGM markets for 2026 growth - Yahoo Finance
GRIMES & Co WEALTH MANAGEMENT LLC Sells 17,554 Shares of DexCom, Inc. $DXCM - MarketBeat
Dexcom reports 13% revenue growth in Q4, reiterates 2025 guidance By Investing.com - Investing.com Nigeria
Barclays Downgrades DexCom (DXCM), Lowers Price Target to $71.00 - GuruFocus
Why This Medical Device Company Is the Top Stock in the S&P 500 Today - Barron's
Dexcom reports 13% rise in preliminary Q4 revenue, issues 2026 outlook - MSN
Why DexCom Is the Top Stock in the S&P 500 Today - Barron's
Barclays Downgrades DexCom to Underweight From Equal Weight, Adjusts Price Target to $71 From $80 - marketscreener.com
DexCom (DXCM) Reports Strong Preliminary Q4 and FY 2025 Revenue Growth - GuruFocus
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
1.21%
자본화:
|
볼륨(24시간):